Human Subjects Protection

FASEB : OPA : Policy Issues

FASEB Policy Statements

Go Back


>	FASEB Celebrates Senate Passage of Genetic Information Nondiscrimination Act (GINA) April 24, 2008

>	FASEB Urges Senate to Pass Genetic Information Nondiscrimination Act (GINA) April 15, 2008

>	FASEB Thanks Office of Human Research Protections for Guidance on HSP February 7, 2007

>	FASEB Urges House to Pass H.R. 493, Genetic Information Nondiscrimination Act January 24, 2007

>	FASEB Urges Senate to Pass S.306, Genetic Nondiscrimination Act February 17, 2005

>	FASEB President Testifies Against Genetic Discrimination July 7, 2004

>	FASEB Joins Coalition of Organizations in Urging Speaker Dennis Hastert to Schedule Immediate House Action on S. 1053, the "Genetic Information Nondiscrimination Act" November 5, 2003

>	FASEB Letter to HHS Regarding Financial Conflicts of Interest June 3, 2003

>	FASEB Urges Key Senators to Pass Genetic Nondiscrimination Legislation March 6, 2003

>	FASEB Writes Senator Kennedy on Genetic Nondiscrimination May 10, 2002

>	Biomedical Research Scientists Urge Senate to Pass Genetic Nondiscrimination Bill May 9, 2002

>	FASEB Letter to HHS re: Proposed Modification to Privacy Rule April 25, 2002

>	Five FASEB Society Members Among Those Recently Installed on AAHRPP Board of Directors November 5, 2001

>	FASEB Joins Coalition of Associations in Objecting to HIPAA Privacy Regulations August 14, 2001

>	Letter to the National Human Research Protection Advisory Committee in reference to draft interim guidance "Financial Relationships in Clinical Research." March 8, 2001

>	FASEB's Response to NBAC Proposal Feb. 15, 2001

>	FASEB Letter to HHS Regarding Financial Conflicts of Interest September 29, 2000

>	FASEB suggests ways to improve oversight of human-subject research

>	FASEB Statement on the Need for National Policy Promoting Use of Human Tissues in Biomedical Research December, 1997

The Federation of American Societies for Experimental Biology (FASEB) advances biological science through collaborative advocacy for research policies that promote scientific progress and education and lead to improvements in human health.